化学合成ポリペプチド薬の世界市場（～2026年）

• 英文タイトル：Global Chemosynthetic Polypeptide Drugs Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY00175 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は化学合成ポリペプチド薬のグローバル市場について調査・分析したレポートです。種類別（バソプレッシン、バシトラシン、イカチバント、コリスチン（ポリミキシンE）・ポリミキシンB、コリスチンメタンスルホン酸塩）市場規模、用途別（病院薬局、小売薬局、ドラッグストア、オンライン販売）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別化学合成ポリペプチド薬の競争状況、市場シェア ・世界の化学合成ポリペプチド薬市場：種類別市場規模 2015年-2020年（バソプレッシン、バシトラシン、イカチバント、コリスチン（ポリミキシンE）・ポリミキシンB、コリスチンメタンスルホン酸塩） ・世界の化学合成ポリペプチド薬市場：種類別市場規模予測 2021年-2026年（バソプレッシン、バシトラシン、イカチバント、コリスチン（ポリミキシンE）・ポリミキシンB、コリスチンメタンスルホン酸塩） ・世界の化学合成ポリペプチド薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、ドラッグストア、オンライン販売） ・世界の化学合成ポリペプチド薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、ドラッグストア、オンライン販売） ・北米の化学合成ポリペプチド薬市場分析：米国、カナダ ・ヨーロッパの化学合成ポリペプチド薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの化学合成ポリペプチド薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の化学合成ポリペプチド薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの化学合成ポリペプチド薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Peptides International、Biovectra、X-Gen Pharmaceuticals、Eli Lilly、F.Hoffmann-La Roche、Amylin Pharmaceuticals、Novo-Nordisk、Amgen、Ipsen ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Chemosynthetic polypeptide drugs are composed of certain amino acids that combine to form a single unit. These drugs do produce a considerable remedial effect on different diseases, however, accompanied by a few side effects. Chemosynthetic polypeptide drugs are considered closely important mainly because of the therapeutic and curative effects it offers. Their prime areas of application are curing of diseases like tumor, metabolism, immunoregulation, cardiovascular diseases, and various other infectious diseases. These chemosynthetic polypeptide drugs are much more influential as compared to the traditional drugs, hence will likely replace the existing pharmaceutical drugs. Currently, there are more than 140 polypeptide drugs available in the global market. Some of the major chemosynthetic polypeptide drugs available in the global market are thymalfasin, thymopentin, somatostatin, octreotide and thyrocalcitonin.
Chemosynthetic polypeptide drugs market has expanded tremendously over the last decade. Major driving factors for the growth of the chemosynthetic polypeptide drugs market, include, increasing need to expand the development of new drugs due to rising number of cancer patients and metabolic diseases like diabetes, and increased government funding for the development of novel drugs. All these factors have fostered towards increasing research and development in the chemosynthetic polypeptide drugs market.

Market Analysis and Insights: Global Chemosynthetic Polypeptide Drugs Market
The global Chemosynthetic Polypeptide Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Chemosynthetic Polypeptide Drugs Scope and Market Size
Chemosynthetic Polypeptide Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chemosynthetic Polypeptide Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Chemosynthetic Polypeptide Drugs market is segmented into
Vasopressin
Bacitracin
Icatibant
Colistin (Polymyxin E) And Polymyxin B
Colistin Methane Sulfonate

Segment by Application, the Chemosynthetic Polypeptide Drugs market is segmented into
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Sales

Regional and Country-level Analysis
The Chemosynthetic Polypeptide Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Chemosynthetic Polypeptide Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Chemosynthetic Polypeptide Drugs Market Share Analysis
Chemosynthetic Polypeptide Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Chemosynthetic Polypeptide Drugs business, the date to enter into the Chemosynthetic Polypeptide Drugs market, Chemosynthetic Polypeptide Drugs product introduction, recent developments, etc.

The major vendors covered:
Peptides International
Biovectra
X-Gen Pharmaceuticals
Eli Lilly
F.Hoffmann-La Roche
Amylin Pharmaceuticals
Novo-Nordisk
Amgen
Ipsen

レポート目次

---

1 Study Coverage
1.1 Chemosynthetic Polypeptide Drugs Product Introduction
1.2 Market Segments
1.3 Key Chemosynthetic Polypeptide Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Chemosynthetic Polypeptide Drugs Market Size Growth Rate by Type
1.4.2 Vasopressin
1.4.3 Bacitracin
1.4.4 Icatibant
1.4.5 Colistin (Polymyxin E) And Polymyxin B
1.4.6 Colistin Methane Sulfonate
1.5 Market by Application
1.5.1 Global Chemosynthetic Polypeptide Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Drug Stores
1.5.5 Online Sales
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Chemosynthetic Polypeptide Drugs Market Size, Estimates and Forecasts
2.1.1 Global Chemosynthetic Polypeptide Drugs Revenue 2015-2026
2.1.2 Global Chemosynthetic Polypeptide Drugs Sales 2015-2026
2.2 Global Chemosynthetic Polypeptide Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Chemosynthetic Polypeptide Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Chemosynthetic Polypeptide Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Chemosynthetic Polypeptide Drugs Competitor Landscape by Players
3.1 Chemosynthetic Polypeptide Drugs Sales by Manufacturers
3.1.1 Chemosynthetic Polypeptide Drugs Sales by Manufacturers (2015-2020)
3.1.2 Chemosynthetic Polypeptide Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Chemosynthetic Polypeptide Drugs Revenue by Manufacturers
3.2.1 Chemosynthetic Polypeptide Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Chemosynthetic Polypeptide Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Chemosynthetic Polypeptide Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Chemosynthetic Polypeptide Drugs Revenue in 2019
3.2.5 Global Chemosynthetic Polypeptide Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Chemosynthetic Polypeptide Drugs Price by Manufacturers
3.4 Chemosynthetic Polypeptide Drugs Manufacturing Base Distribution, Product Types
3.4.1 Chemosynthetic Polypeptide Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Chemosynthetic Polypeptide Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Chemosynthetic Polypeptide Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Chemosynthetic Polypeptide Drugs Market Size by Type (2015-2020)
4.1.1 Global Chemosynthetic Polypeptide Drugs Sales by Type (2015-2020)
4.1.2 Global Chemosynthetic Polypeptide Drugs Revenue by Type (2015-2020)
4.1.3 Chemosynthetic Polypeptide Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Chemosynthetic Polypeptide Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Chemosynthetic Polypeptide Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Chemosynthetic Polypeptide Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Chemosynthetic Polypeptide Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Chemosynthetic Polypeptide Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Chemosynthetic Polypeptide Drugs Market Size by Application (2015-2020)
5.1.1 Global Chemosynthetic Polypeptide Drugs Sales by Application (2015-2020)
5.1.2 Global Chemosynthetic Polypeptide Drugs Revenue by Application (2015-2020)
5.1.3 Chemosynthetic Polypeptide Drugs Price by Application (2015-2020)
5.2 Chemosynthetic Polypeptide Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Chemosynthetic Polypeptide Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Chemosynthetic Polypeptide Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Chemosynthetic Polypeptide Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Chemosynthetic Polypeptide Drugs by Country
6.1.1 North America Chemosynthetic Polypeptide Drugs Sales by Country
6.1.2 North America Chemosynthetic Polypeptide Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Chemosynthetic Polypeptide Drugs Market Facts & Figures by Type
6.3 North America Chemosynthetic Polypeptide Drugs Market Facts & Figures by Application

7 Europe
7.1 Europe Chemosynthetic Polypeptide Drugs by Country
7.1.1 Europe Chemosynthetic Polypeptide Drugs Sales by Country
7.1.2 Europe Chemosynthetic Polypeptide Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Chemosynthetic Polypeptide Drugs Market Facts & Figures by Type
7.3 Europe Chemosynthetic Polypeptide Drugs Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Chemosynthetic Polypeptide Drugs by Region
8.1.1 Asia Pacific Chemosynthetic Polypeptide Drugs Sales by Region
8.1.2 Asia Pacific Chemosynthetic Polypeptide Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Chemosynthetic Polypeptide Drugs Market Facts & Figures by Type
8.3 Asia Pacific Chemosynthetic Polypeptide Drugs Market Facts & Figures by Application

9 Latin America
9.1 Latin America Chemosynthetic Polypeptide Drugs by Country
9.1.1 Latin America Chemosynthetic Polypeptide Drugs Sales by Country
9.1.2 Latin America Chemosynthetic Polypeptide Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Chemosynthetic Polypeptide Drugs Market Facts & Figures by Type
9.3 Central & South America Chemosynthetic Polypeptide Drugs Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Chemosynthetic Polypeptide Drugs by Country
10.1.1 Middle East and Africa Chemosynthetic Polypeptide Drugs Sales by Country
10.1.2 Middle East and Africa Chemosynthetic Polypeptide Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Chemosynthetic Polypeptide Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Chemosynthetic Polypeptide Drugs Market Facts & Figures by Application

11 Company Profiles
11.1 Peptides International
11.1.1 Peptides International Corporation Information
11.1.2 Peptides International Description and Business Overview
11.1.3 Peptides International Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Peptides International Chemosynthetic Polypeptide Drugs Products Offered
11.1.5 Peptides International Related Developments
11.2 Biovectra
11.2.1 Biovectra Corporation Information
11.2.2 Biovectra Description and Business Overview
11.2.3 Biovectra Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Biovectra Chemosynthetic Polypeptide Drugs Products Offered
11.2.5 Biovectra Related Developments
11.3 X-Gen Pharmaceuticals
11.3.1 X-Gen Pharmaceuticals Corporation Information
11.3.2 X-Gen Pharmaceuticals Description and Business Overview
11.3.3 X-Gen Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.3.4 X-Gen Pharmaceuticals Chemosynthetic Polypeptide Drugs Products Offered
11.3.5 X-Gen Pharmaceuticals Related Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Corporation Information
11.4.2 Eli Lilly Description and Business Overview
11.4.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Eli Lilly Chemosynthetic Polypeptide Drugs Products Offered
11.4.5 Eli Lilly Related Developments
11.5 F.Hoffmann-La Roche
11.5.1 F.Hoffmann-La Roche Corporation Information
11.5.2 F.Hoffmann-La Roche Description and Business Overview
11.5.3 F.Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.5.4 F.Hoffmann-La Roche Chemosynthetic Polypeptide Drugs Products Offered
11.5.5 F.Hoffmann-La Roche Related Developments
11.6 Amylin Pharmaceuticals
11.6.1 Amylin Pharmaceuticals Corporation Information
11.6.2 Amylin Pharmaceuticals Description and Business Overview
11.6.3 Amylin Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Amylin Pharmaceuticals Chemosynthetic Polypeptide Drugs Products Offered
11.6.5 Amylin Pharmaceuticals Related Developments
11.7 Novo-Nordisk
11.7.1 Novo-Nordisk Corporation Information
11.7.2 Novo-Nordisk Description and Business Overview
11.7.3 Novo-Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Novo-Nordisk Chemosynthetic Polypeptide Drugs Products Offered
11.7.5 Novo-Nordisk Related Developments
11.8 Amgen
11.8.1 Amgen Corporation Information
11.8.2 Amgen Description and Business Overview
11.8.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Amgen Chemosynthetic Polypeptide Drugs Products Offered
11.8.5 Amgen Related Developments
11.9 Ipsen
11.9.1 Ipsen Corporation Information
11.9.2 Ipsen Description and Business Overview
11.9.3 Ipsen Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Ipsen Chemosynthetic Polypeptide Drugs Products Offered
11.9.5 Ipsen Related Developments
11.1 Peptides International
11.1.1 Peptides International Corporation Information
11.1.2 Peptides International Description and Business Overview
11.1.3 Peptides International Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Peptides International Chemosynthetic Polypeptide Drugs Products Offered
11.1.5 Peptides International Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Chemosynthetic Polypeptide Drugs Market Estimates and Projections by Region
12.1.1 Global Chemosynthetic Polypeptide Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Chemosynthetic Polypeptide Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Chemosynthetic Polypeptide Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Chemosynthetic Polypeptide Drugs Sales Forecast (2021-2026)
12.2.2 North America: Chemosynthetic Polypeptide Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Chemosynthetic Polypeptide Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Chemosynthetic Polypeptide Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Chemosynthetic Polypeptide Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Chemosynthetic Polypeptide Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Chemosynthetic Polypeptide Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Chemosynthetic Polypeptide Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Chemosynthetic Polypeptide Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Chemosynthetic Polypeptide Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Chemosynthetic Polypeptide Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Chemosynthetic Polypeptide Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Chemosynthetic Polypeptide Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Chemosynthetic Polypeptide Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Chemosynthetic Polypeptide Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Chemosynthetic Polypeptide Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Chemosynthetic Polypeptide Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Chemosynthetic Polypeptide Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Chemosynthetic Polypeptide Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Chemosynthetic Polypeptide Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Chemosynthetic Polypeptide Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Chemosynthetic Polypeptide Drugs Market Segments
Table 2. Ranking of Global Top Chemosynthetic Polypeptide Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Chemosynthetic Polypeptide Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Vasopressin
Table 5. Major Manufacturers of Bacitracin
Table 6. Major Manufacturers of Icatibant
Table 7. Major Manufacturers of Colistin (Polymyxin E) And Polymyxin B
Table 8. Major Manufacturers of Colistin Methane Sulfonate
Table 9. Global Chemosynthetic Polypeptide Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 10. Global Chemosynthetic Polypeptide Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 11. Global Chemosynthetic Polypeptide Drugs Sales by Regions 2015-2020 (K MT)
Table 12. Global Chemosynthetic Polypeptide Drugs Sales Market Share by Regions (2015-2020)
Table 13. Global Chemosynthetic Polypeptide Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Chemosynthetic Polypeptide Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 15. Global Chemosynthetic Polypeptide Drugs Sales Share by Manufacturers (2015-2020)
Table 16. Global Chemosynthetic Polypeptide Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Chemosynthetic Polypeptide Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemosynthetic Polypeptide Drugs as of 2019)
Table 18. Chemosynthetic Polypeptide Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Chemosynthetic Polypeptide Drugs Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Chemosynthetic Polypeptide Drugs Price (2015-2020) (USD/MT)
Table 21. Chemosynthetic Polypeptide Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Chemosynthetic Polypeptide Drugs Product Type
Table 23. Date of International Manufacturers Enter into Chemosynthetic Polypeptide Drugs Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Chemosynthetic Polypeptide Drugs Sales by Type (2015-2020) (K MT)
Table 26. Global Chemosynthetic Polypeptide Drugs Sales Share by Type (2015-2020)
Table 27. Global Chemosynthetic Polypeptide Drugs Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Chemosynthetic Polypeptide Drugs Revenue Share by Type (2015-2020)
Table 29. Chemosynthetic Polypeptide Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 30. Global Chemosynthetic Polypeptide Drugs Sales by Application (2015-2020) (K MT)
Table 31. Global Chemosynthetic Polypeptide Drugs Sales Share by Application (2015-2020)
Table 32. North America Chemosynthetic Polypeptide Drugs Sales by Country (2015-2020) (K MT)
Table 33. North America Chemosynthetic Polypeptide Drugs Sales Market Share by Country (2015-2020)
Table 34. North America Chemosynthetic Polypeptide Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Chemosynthetic Polypeptide Drugs Revenue Market Share by Country (2015-2020)
Table 36. North America Chemosynthetic Polypeptide Drugs Sales by Type (2015-2020) (K MT)
Table 37. North America Chemosynthetic Polypeptide Drugs Sales Market Share by Type (2015-2020)
Table 38. North America Chemosynthetic Polypeptide Drugs Sales by Application (2015-2020) (K MT)
Table 39. North America Chemosynthetic Polypeptide Drugs Sales Market Share by Application (2015-2020)
Table 40. Europe Chemosynthetic Polypeptide Drugs Sales by Country (2015-2020) (K MT)
Table 41. Europe Chemosynthetic Polypeptide Drugs Sales Market Share by Country (2015-2020)
Table 42. Europe Chemosynthetic Polypeptide Drugs Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Chemosynthetic Polypeptide Drugs Revenue Market Share by Country (2015-2020)
Table 44. Europe Chemosynthetic Polypeptide Drugs Sales by Type (2015-2020) (K MT)
Table 45. Europe Chemosynthetic Polypeptide Drugs Sales Market Share by Type (2015-2020)
Table 46. Europe Chemosynthetic Polypeptide Drugs Sales by Application (2015-2020) (K MT)
Table 47. Europe Chemosynthetic Polypeptide Drugs Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Chemosynthetic Polypeptide Drugs Sales by Region (2015-2020) (K MT)
Table 49. Asia Pacific Chemosynthetic Polypeptide Drugs Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Chemosynthetic Polypeptide Drugs Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Chemosynthetic Polypeptide Drugs Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Chemosynthetic Polypeptide Drugs Sales by Type (2015-2020) (K MT)
Table 53. Asia Pacific Chemosynthetic Polypeptide Drugs Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Chemosynthetic Polypeptide Drugs Sales by Application (2015-2020) (K MT)
Table 55. Asia Pacific Chemosynthetic Polypeptide Drugs Sales Market Share by Application (2015-2020)
Table 56. Latin America Chemosynthetic Polypeptide Drugs Sales by Country (2015-2020) (K MT)
Table 57. Latin America Chemosynthetic Polypeptide Drugs Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Chemosynthetic Polypeptide Drugs Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Chemosynthetic Polypeptide Drugs Revenue Market Share by Country (2015-2020)
Table 60. Latin America Chemosynthetic Polypeptide Drugs Sales by Type (2015-2020) (K MT)
Table 61. Latin America Chemosynthetic Polypeptide Drugs Sales Market Share by Type (2015-2020)
Table 62. Latin America Chemosynthetic Polypeptide Drugs Sales by Application (2015-2020) (K MT)
Table 63. Latin America Chemosynthetic Polypeptide Drugs Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Chemosynthetic Polypeptide Drugs Sales by Country (2015-2020) (K MT)
Table 65. Middle East and Africa Chemosynthetic Polypeptide Drugs Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Chemosynthetic Polypeptide Drugs Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Chemosynthetic Polypeptide Drugs Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Chemosynthetic Polypeptide Drugs Sales by Type (2015-2020) (K MT)
Table 69. Middle East and Africa Chemosynthetic Polypeptide Drugs Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Chemosynthetic Polypeptide Drugs Sales by Application (2015-2020) (K MT)
Table 71. Middle East and Africa Chemosynthetic Polypeptide Drugs Sales Market Share by Application (2015-2020)
Table 72. Peptides International Corporation Information
Table 73. Peptides International Description and Major Businesses
Table 74. Peptides International Chemosynthetic Polypeptide Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 75. Peptides International Product
Table 76. Peptides International Recent Development
Table 77. Biovectra Corporation Information
Table 78. Biovectra Description and Major Businesses
Table 79. Biovectra Chemosynthetic Polypeptide Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. Biovectra Product
Table 81. Biovectra Recent Development
Table 82. X-Gen Pharmaceuticals Corporation Information
Table 83. X-Gen Pharmaceuticals Description and Major Businesses
Table 84. X-Gen Pharmaceuticals Chemosynthetic Polypeptide Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. X-Gen Pharmaceuticals Product
Table 86. X-Gen Pharmaceuticals Recent Development
Table 87. Eli Lilly Corporation Information
Table 88. Eli Lilly Description and Major Businesses
Table 89. Eli Lilly Chemosynthetic Polypeptide Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. Eli Lilly Product
Table 91. Eli Lilly Recent Development
Table 92. F.Hoffmann-La Roche Corporation Information
Table 93. F.Hoffmann-La Roche Description and Major Businesses
Table 94. F.Hoffmann-La Roche Chemosynthetic Polypeptide Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. F.Hoffmann-La Roche Product
Table 96. F.Hoffmann-La Roche Recent Development
Table 97. Amylin Pharmaceuticals Corporation Information
Table 98. Amylin Pharmaceuticals Description and Major Businesses
Table 99. Amylin Pharmaceuticals Chemosynthetic Polypeptide Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. Amylin Pharmaceuticals Product
Table 101. Amylin Pharmaceuticals Recent Development
Table 102. Novo-Nordisk Corporation Information
Table 103. Novo-Nordisk Description and Major Businesses
Table 104. Novo-Nordisk Chemosynthetic Polypeptide Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. Novo-Nordisk Product
Table 106. Novo-Nordisk Recent Development
Table 107. Amgen Corporation Information
Table 108. Amgen Description and Major Businesses
Table 109. Amgen Chemosynthetic Polypeptide Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. Amgen Product
Table 111. Amgen Recent Development
Table 112. Ipsen Corporation Information
Table 113. Ipsen Description and Major Businesses
Table 114. Ipsen Chemosynthetic Polypeptide Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. Ipsen Product
Table 116. Ipsen Recent Development
Table 117. Global Chemosynthetic Polypeptide Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 118. Global Chemosynthetic Polypeptide Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 119. Global Chemosynthetic Polypeptide Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 120. Global Chemosynthetic Polypeptide Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 121. North America: Chemosynthetic Polypeptide Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 122. North America: Chemosynthetic Polypeptide Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Europe: Chemosynthetic Polypeptide Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 124. Europe: Chemosynthetic Polypeptide Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Asia Pacific: Chemosynthetic Polypeptide Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 126. Asia Pacific: Chemosynthetic Polypeptide Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 127. Latin America: Chemosynthetic Polypeptide Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 128. Latin America: Chemosynthetic Polypeptide Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Middle East and Africa: Chemosynthetic Polypeptide Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 130. Middle East and Africa: Chemosynthetic Polypeptide Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 132. Key Challenges
Table 133. Market Risks
Table 134. Main Points Interviewed from Key Chemosynthetic Polypeptide Drugs Players
Table 135. Chemosynthetic Polypeptide Drugs Customers List
Table 136. Chemosynthetic Polypeptide Drugs Distributors List
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Chemosynthetic Polypeptide Drugs Product Picture
Figure 2. Global Chemosynthetic Polypeptide Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Vasopressin Product Picture
Figure 4. Bacitracin Product Picture
Figure 5. Icatibant Product Picture
Figure 6. Colistin (Polymyxin E) And Polymyxin B Product Picture
Figure 7. Colistin Methane Sulfonate Product Picture
Figure 8. Global Chemosynthetic Polypeptide Drugs Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Drug Stores
Figure 12. Online Sales
Figure 13. Chemosynthetic Polypeptide Drugs Report Years Considered
Figure 14. Global Chemosynthetic Polypeptide Drugs Market Size 2015-2026 (US$ Million)
Figure 15. Global Chemosynthetic Polypeptide Drugs Sales 2015-2026 (K MT)
Figure 16. Global Chemosynthetic Polypeptide Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Chemosynthetic Polypeptide Drugs Sales Market Share by Region (2015-2020)
Figure 18. Global Chemosynthetic Polypeptide Drugs Sales Market Share by Region in 2019
Figure 19. Global Chemosynthetic Polypeptide Drugs Revenue Market Share by Region (2015-2020)
Figure 20. Global Chemosynthetic Polypeptide Drugs Revenue Market Share by Region in 2019
Figure 21. Global Chemosynthetic Polypeptide Drugs Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Chemosynthetic Polypeptide Drugs Revenue in 2019
Figure 23. Chemosynthetic Polypeptide Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Chemosynthetic Polypeptide Drugs Sales Market Share by Type (2015-2020)
Figure 25. Global Chemosynthetic Polypeptide Drugs Sales Market Share by Type in 2019
Figure 26. Global Chemosynthetic Polypeptide Drugs Revenue Market Share by Type (2015-2020)
Figure 27. Global Chemosynthetic Polypeptide Drugs Revenue Market Share by Type in 2019
Figure 28. Global Chemosynthetic Polypeptide Drugs Market Share by Price Range (2015-2020)
Figure 29. Global Chemosynthetic Polypeptide Drugs Sales Market Share by Application (2015-2020)
Figure 30. Global Chemosynthetic Polypeptide Drugs Sales Market Share by Application in 2019
Figure 31. Global Chemosynthetic Polypeptide Drugs Revenue Market Share by Application (2015-2020)
Figure 32. Global Chemosynthetic Polypeptide Drugs Revenue Market Share by Application in 2019
Figure 33. North America Chemosynthetic Polypeptide Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 34. North America Chemosynthetic Polypeptide Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Chemosynthetic Polypeptide Drugs Sales Market Share by Country in 2019
Figure 36. North America Chemosynthetic Polypeptide Drugs Revenue Market Share by Country in 2019
Figure 37. U.S. Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 38. U.S. Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 40. Canada Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Chemosynthetic Polypeptide Drugs Market Share by Type in 2019
Figure 42. North America Chemosynthetic Polypeptide Drugs Market Share by Application in 2019
Figure 43. Europe Chemosynthetic Polypeptide Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 44. Europe Chemosynthetic Polypeptide Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Chemosynthetic Polypeptide Drugs Sales Market Share by Country in 2019
Figure 46. Europe Chemosynthetic Polypeptide Drugs Revenue Market Share by Country in 2019
Figure 47. Germany Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 48. Germany Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 50. France Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 52. U.K. Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 54. Italy Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 56. Russia Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Chemosynthetic Polypeptide Drugs Market Share by Type in 2019
Figure 58. Europe Chemosynthetic Polypeptide Drugs Market Share by Application in 2019
Figure 59. Asia Pacific Chemosynthetic Polypeptide Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 60. Asia Pacific Chemosynthetic Polypeptide Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Chemosynthetic Polypeptide Drugs Sales Market Share by Region in 2019
Figure 62. Asia Pacific Chemosynthetic Polypeptide Drugs Revenue Market Share by Region in 2019
Figure 63. China Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 64. China Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 66. Japan Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 68. South Korea Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 70. India Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 72. Australia Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 74. Taiwan Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 76. Indonesia Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 78. Thailand Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 80. Malaysia Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 82. Philippines Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 84. Vietnam Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Chemosynthetic Polypeptide Drugs Market Share by Type in 2019
Figure 86. Asia Pacific Chemosynthetic Polypeptide Drugs Market Share by Application in 2019
Figure 87. Latin America Chemosynthetic Polypeptide Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 88. Latin America Chemosynthetic Polypeptide Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Chemosynthetic Polypeptide Drugs Sales Market Share by Country in 2019
Figure 90. Latin America Chemosynthetic Polypeptide Drugs Revenue Market Share by Country in 2019
Figure 91. Mexico Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 92. Mexico Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 94. Brazil Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 96. Argentina Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Chemosynthetic Polypeptide Drugs Market Share by Type in 2019
Figure 98. Latin America Chemosynthetic Polypeptide Drugs Market Share by Application in 2019
Figure 99. Middle East and Africa Chemosynthetic Polypeptide Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 100. Middle East and Africa Chemosynthetic Polypeptide Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Chemosynthetic Polypeptide Drugs Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Chemosynthetic Polypeptide Drugs Revenue Market Share by Country in 2019
Figure 103. Turkey Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 104. Turkey Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 106. Saudi Arabia Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Chemosynthetic Polypeptide Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 108. U.A.E Chemosynthetic Polypeptide Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Chemosynthetic Polypeptide Drugs Market Share by Type in 2019
Figure 110. Middle East and Africa Chemosynthetic Polypeptide Drugs Market Share by Application in 2019
Figure 111. North America Chemosynthetic Polypeptide Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. North America Chemosynthetic Polypeptide Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Chemosynthetic Polypeptide Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Europe Chemosynthetic Polypeptide Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Chemosynthetic Polypeptide Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Asia Pacific Chemosynthetic Polypeptide Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Chemosynthetic Polypeptide Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Latin America Chemosynthetic Polypeptide Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Chemosynthetic Polypeptide Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Middle East and Africa Chemosynthetic Polypeptide Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed

---